全文获取类型
收费全文 | 5443篇 |
免费 | 494篇 |
国内免费 | 134篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 70篇 |
妇产科学 | 25篇 |
基础医学 | 99篇 |
口腔科学 | 9篇 |
临床医学 | 780篇 |
内科学 | 946篇 |
皮肤病学 | 7篇 |
神经病学 | 72篇 |
特种医学 | 1877篇 |
外国民族医学 | 1篇 |
外科学 | 578篇 |
综合类 | 906篇 |
预防医学 | 154篇 |
眼科学 | 11篇 |
药学 | 157篇 |
7篇 | |
中国医学 | 63篇 |
肿瘤学 | 303篇 |
出版年
2024年 | 10篇 |
2023年 | 94篇 |
2022年 | 134篇 |
2021年 | 177篇 |
2020年 | 211篇 |
2019年 | 164篇 |
2018年 | 125篇 |
2017年 | 139篇 |
2016年 | 192篇 |
2015年 | 175篇 |
2014年 | 253篇 |
2013年 | 260篇 |
2012年 | 288篇 |
2011年 | 336篇 |
2010年 | 313篇 |
2009年 | 375篇 |
2008年 | 303篇 |
2007年 | 369篇 |
2006年 | 343篇 |
2005年 | 326篇 |
2004年 | 268篇 |
2003年 | 243篇 |
2002年 | 238篇 |
2001年 | 184篇 |
2000年 | 127篇 |
1999年 | 113篇 |
1998年 | 97篇 |
1997年 | 68篇 |
1996年 | 45篇 |
1995年 | 29篇 |
1994年 | 23篇 |
1993年 | 18篇 |
1992年 | 10篇 |
1991年 | 6篇 |
1990年 | 7篇 |
1989年 | 1篇 |
1987年 | 1篇 |
1986年 | 2篇 |
1985年 | 2篇 |
1984年 | 2篇 |
排序方式: 共有6071条查询结果,搜索用时 12 毫秒
181.
目的 探析腔内介入治疗下肢动脉硬化闭塞症的临床效果.方法 选择本院2008年2月~2014年2月期间收治的42例下肢动脉硬化闭塞症患者为研究对象,所有患者均在DSA机的全程监测下接受腔内介入治疗,术后患者还需接受相应的防感染治疗,主要包括抗凝、行溶栓以及抑制血小板凝聚等,观察治疗成功率.结果 治疗成功率为97.62%,患者的血流不畅通情况得到明显改善,患肢静息痛、肢体末端发凉麻木以及严重间歇性跛行也明显好转.结论 使用腔内介入治疗术治疗下肢动脉硬化闭塞症不仅可以有效降低并发症的发生率,同时还可以提高血管的重建率,消除流入与流出通道之间的相互影响,减轻了患者的经济负担.此外,其还具有微创、有效、安全、适用范围广以及术后恢复速度快等优点,值得临床推广. 相似文献
182.
183.
Andrew Peters MD Afaq Motiwala MD Brian O'Neill MD Pravin Patil MD 《Catheterization and cardiovascular interventions》2021,97(5):E719-E723
The use of the Watchman left atrial appendage occlusion device (Boston Scientific Inc.) is becoming increasingly frequent in patients with atrial fibrillation. Cardiac computed tomography (CT) for device sizing pre-procedure can help facilitate more accurate device selection compared with transesophageal echo (TEE) alone. CT can also help identify minor lobes and trabeculations that may not be apparent on TEE. We report a series of three cases to highlight the utility of a novel application of CT-TEE fusion imaging to provide procedural guidance during Watchman implant and to assess for peri-device leak post-implant. 相似文献
184.
185.
186.
目的 评估超声引导下腹腔神经丛毁损(CPN)治疗上腹部癌痛的安全性和有效性。方法 对15例进展性上腹部癌痛患者行超声引导下CPN,利用视觉模拟量表(VAS)评分进行评估,记录CPN治疗前和治疗后即刻、1天、1周、1个月、3个月患者疼痛程度,并进行统计学分析。结果 2例因治疗前评估无安全穿刺路径而被剔除。成功实施超声引导下CPN治疗13例。治疗后13例患者VAS评分明显低于治疗前(P<0.05)。治疗过程中无严重并发症发生。3例发生穿刺部位疼痛,24 h后缓解;2例肠蠕动增快而出现腹泻;1例出现恶心、呕吐;1例术后出现低血压。结论 超声引导下CPN安全有效,可作为微创治疗上腹部癌痛的方法之一。 相似文献
187.
Endobronchial ultrasound 总被引:11,自引:0,他引:11
During flexible fiberoptic bronchoscopy (FB), a solitary pulmonary nodule (SPN) is sampled by means of transbronchial needle aspiration (TBNA), brush, or transbronchial lung biopsy under fluoroscopy; and mediastinal lymph nodes are sampled using "blind" TBNA. Endobronchial ultrasound (EBUS) was developed to help visualize the lesion at the time of biopsy in order to improve the diagnostic yield. METHODS: There are two types of EBUS techniques: using a radial probe (RP) with a rotating transducer at the distal tip, which produces a 360 degrees image to the long axis of the bronchoscope; and using an EBUS bronchoscope with a linear transducer at its distal tip, producing a 50 degrees image parallel to its long axis. RESULTS: In biopsies of SPNs < 2 cm using an RP, EBUS demonstrates a higher diagnostic yield than conventional FB techniques. With mediastinal and hilar nodal stations, except for the subcarina, EBUS shows a higher yield over blind TBNA. The current procedural terminology code for EBUS is 31620, a "ZZZ" code submitted in addition to other performed procedures (31622-31638). In 2007, an estimate of physician Medicare reimbursement for EBUS is $70.49. Reimbursement is locality dependent and based on economic-exchange conversion factors. Incorporating an ultrasound image into the report substantiates the use of this technique. Limitations: The physician must learn ultrasound image interpretation and the EBUS technique, and be skilled in TBNA. Maintaining competency requires frequent performance of EBUS. CONCLUSION: EBUS-directed biopsy improves the yield over conventional FB for SPNs < 2 cm and for most mediastinal or hilar nodal stations. This reduces the need to conduct additional diagnostic procedures. 相似文献
188.
Karina M Carlson Henri Justino Richard E O'Brien V Vivian Dimas Glenn T Leonard Ricardo H Pignatelli Charles E Mullins E O'Brian Smith Ronald G Grifka 《Catheterization and cardiovascular interventions》2005,66(3):390-396
The objective of this study was to evaluate a new technique of sizing atrial septal defects (ASDs) for transcatheter device closure. ASD closure using the Amplatzer septal occluder (ASO) device is commonly performed. Complications, including arrhythmias, pericardial effusions, and perforations, may be related to oversizing ASDs and choosing larger devices. Two methods were used to size ASDs using a compliant balloon. In some patients, the balloon was inflated until a waist was visible [(+)waist]; in others, only until no shunting was demonstrable by echocardiogram [echo; (-)waist]. The device was selected and implanted using standard procedure and echo guidance. One hundred seventeen patients underwent secundum ASD closure with an ASO device. There were 43 patients in the (-)waist group and 74 in the (+)waist group. All devices were implanted successfully. The initial echo ASD diameter was larger in the (-)waist group compared to the (+)waist group (P = 0.01). There was a smaller difference between the initial echo and balloon-sized ASD diameters in the (-)waist group (P < 0.02). ASO device size implanted (in mm greater than echo ASD diameter) was smaller in the (-)waist group (P < 0.01). There were 0/43 complications in the (-)waist group and 5/74 in the (+)waist group. The complete closure rate was the same in both groups. Sizing an ASD by inflating a compliant balloon just until shunting is eliminated, and not until a waist is visible, results in less overstretching of the ASD and selection of a smaller ASO device, achieving similar closure rates and potentially fewer complications. 相似文献
189.
Fujita N Noda Y Kobayashi G Ito K Obana T Horaguchi J Takasawa O Sugawara T 《Journal of gastroenterology》2008,43(8):637-640
Endosonography-guided biliary drainage (ESBD) is now gaining acceptance as a useful alternative for the management of obstructive jaundice.(1) At present, ESBD is used mainly to establish an anastomosis between the biliary tree and the duodenum, stomach, jejunum, or esophagus by placing a stent so as to bridge the bile duct and alimentary tract. We herein report a new application of ESBD, that is, its temporary use for gaining access to the bile duct in order to deploy a self-expandable metallic stent (SEMS) via the transhepatic route. In a patient with pylorus stenosis due to advanced gastric cancer with extrahepatic bile duct obstruction caused by nodal metastasis, a plastic stent was placed temporarily by ESBD to bridge the esophagus and the left hepatic duct. Ten days later, the stent was retrieved, leaving a guidewire in the bile duct, and a delivery unit of a SEMS was introduced into the bile duct over the guidewire via the sinus tract. The SEMS was then successfully deployed through the stenosis. No stent was left in the sinus tract. This procedure yields a mature fistula through which a delivery unit can be safely introduced into the bile duct followed by uneventful deployment of a SEMS. 相似文献
190.
目的 探讨应用正丁基-2-氰丙烯酸盐(NBCA)经门静脉硬化治疗胃底静脉曲张(GFV)的临床疗效及安全性. 方法经胃镜确诊为GFV的21例门静脉高压症患者接受了经门静脉硬化治疗,所有患者采取经皮经肝或经脾穿刺门静脉造影及供血静脉造影,然后用微导管插管到曲张静脉内,注入硬化剂NBCA和碘化油混合乳剂(NBCA LP).对8例伴有高流量胃肾分流者,治疗前经股静脉、左肾静脉放置阻塞球囊导管于分流道,治疗时扩张球囊阻塞分流道.随访评价包括血清肝功能指标变化、内镜复查及再出血情况. 结果 20例GFV成功进行硬化治疗(95.2%);未成功的1例,为高流量胃肾分流者,术中因未有阻塞球囊导管,未能进行治疗.5例少量NBCA-LP进入到肺动脉,2例出现一过性刺激性咳嗽,2例发生门静脉分支栓塞.术后6个月,血清ALT、白蛋白、凝血酶原时间明显改善,血清总胆红素变化不明显.15例患者3个月胃镜复查,GFV消失10例,好转4例,有效率93.3%(14/15),3例食管静脉曲张较术前加重(20.0%).平均随访(16.7±8.8)个月,再出血4例,1年累积再出血率为9.52%.结论 应用NBCA经门静脉硬化治疗是控制GFV破裂出血的安全有效方法,微导管技术、球囊逆行阻塞胃肾分流道技术是提高疗效、防止肺栓塞的关键. 相似文献